Transferrin Receptor 2: Evidence for Ligand-induced Stabilization and Redirection to a Recycling Pathway

Overview

Journal Mol Biol Cell

Specialties Cell Biology
Molecular Biology

Date 2006 Dec 22

PMID 17182845

Citations 46

Authors

Martha B Johnson

Juxing Chen

Nicholas Murchison

Frank A Green

Caroline A Enns

Affiliations

Soon will be listed here.

Abstract

Transferrin receptor 2 (TfR2) is a homologue of transferrin receptor 1 (TfR1), the protein that delivers iron to cells through receptor-mediated endocytosis of diferric transferrin (Fe(2)Tf). TfR2 also binds Fe(2)Tf, but it seems to function primarily in the regulation of systemic iron homeostasis. In contrast to TfR1, the trafficking of TfR2 within the cell has not been extensively characterized. Previously, we showed that Fe(2)Tf increases TfR2 stability, suggesting that trafficking of TfR2 may be regulated by interaction with its ligand. In the present study, therefore, we sought to identify the mode of TfR2 degradation, to characterize TfR2 trafficking, and to determine how Fe(2)Tf stabilizes TfR2. Stabilization of TfR2 by bafilomycin implies that TfR2 traffics to the lysosome for degradation. Confocal microscopy reveals that treatment of cells with Fe(2)Tf increases the fraction of TfR2 localizing to recycling endosomes and decreases the fraction of TfR2 localizing to late endosomes. Mutational analysis of TfR2 shows that the mutation G679A, which blocks TfR2 binding to Fe(2)Tf, increases the rate of receptor turnover and prevents stabilization by Fe(2)Tf, indicating a direct role of Fe(2)Tf in TfR2 stabilization. The mutation Y23A in the cytoplasmic domain of TfR2 inhibits its internalization and degradation, implicating YQRV as an endocytic motif.

Citing Articles

Dominant ARF3 variants disrupt Golgi integrity and cause a neurodevelopmental disorder recapitulated in zebrafish.

Fasano G, Muto V, Radio F, Venditti M, Mosaddeghzadeh N, Coppola S Nat Commun. 2022; 13(1):6841.

PMID: 36369169 PMC: 9652361. DOI: 10.1038/s41467-022-34354-x.

Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.

Di Modica S, Tanzi E, Olivari V, Lidonnici M, Pettinato M, Pagani A Am J Hematol. 2022; 97(10):1324-1336.

PMID: 36071579 PMC: 9540808. DOI: 10.1002/ajh.26673.

Physiology and Inflammation Driven Pathophysiology of Iron Homeostasis-Mechanistic Insights into Anemia of Inflammation and Its Treatment.

Lanser L, Fuchs D, Kurz K, Weiss G Nutrients. 2021; 13(11).

PMID: 34835988 PMC: 8619077. DOI: 10.3390/nu13113732.

Coordination of iron homeostasis by bone morphogenetic proteins: Current understanding and unanswered questions.

Fisher A, Babitt J Dev Dyn. 2021; 251(1):26-46.

PMID: 33993583 PMC: 8594283. DOI: 10.1002/dvdy.372.

Transferrin Receptors in Erythropoiesis.

Richard C, Verdier F Int J Mol Sci. 2020; 21(24).

PMID: 33352721 PMC: 7766611. DOI: 10.3390/ijms21249713.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Bowman E, Siebers A, Altendorf K . Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A. 1988; 85(21):7972-6. PMC: 282335. DOI: 10.1073/pnas.85.21.7972. View

Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J . Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet. 2002; 33(1):21-2. DOI: 10.1038/ng1053. View

Nemeth E, Roetto A, Garozzo G, Ganz T, Camaschella C . Hepcidin is decreased in TFR2 hemochromatosis. Blood. 2004; 105(4):1803-6. DOI: 10.1182/blood-2004-08-3042. View

Fleming R, Migas M, Holden C, Waheed A, Britton R, Tomatsu S . Transferrin receptor 2: continued expression in mouse liver in the face of iron overload and in hereditary hemochromatosis. Proc Natl Acad Sci U S A. 2000; 97(5):2214-9. PMC: 15780. DOI: 10.1073/pnas.040548097. View

Chavrier P, Parton R, Hauri H, Simons K, Zerial M . Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell. 1990; 62(2):317-29. DOI: 10.1016/0092-8674(90)90369-p. View

Robb A, Wessling-Resnick M . Regulation of transferrin receptor 2 protein levels by transferrin. Blood. 2004; 104(13):4294-9. DOI: 10.1182/blood-2004-06-2481. View

Mellman I, Simons K . The Golgi complex: in vitro veritas?. Cell. 1992; 68(5):829-40. PMC: 7133332. DOI: 10.1016/0092-8674(92)90027-a. View

Kawabata H, Germain R, Vuong P, Nakamaki T, Said J, Koeffler H . Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J Biol Chem. 2000; 275(22):16618-25. DOI: 10.1074/jbc.M908846199. View

10.

West Jr A, Bennett M, Sellers V, Andrews N, Enns C, Bjorkman P . Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE. J Biol Chem. 2000; 275(49):38135-8. DOI: 10.1074/jbc.C000664200. View

11.

Sorkin A, Von Zastrow M . Signal transduction and endocytosis: close encounters of many kinds. Nat Rev Mol Cell Biol. 2002; 3(8):600-14. DOI: 10.1038/nrm883. View

12.

Tsunoo H, SUSSMAN H . Placental transferrin receptor. Evaluation of the presence of endogenous ligand on specific binding. J Biol Chem. 1983; 258(7):4118-22. View

13.

Zhang A, Xiong S, Tsukamoto H, Enns C . Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood. 2003; 103(4):1509-14. DOI: 10.1182/blood-2003-07-2378. View

14.

Watts C . Rapid endocytosis of the transferrin receptor in the absence of bound transferrin. J Cell Biol. 1985; 100(2):633-7. PMC: 2113434. DOI: 10.1083/jcb.100.2.633. View

15.

Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M . The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat Genet. 2000; 25(1):14-5. DOI: 10.1038/75534. View

16.

Marks M, Ohno H, Kirchnausen T, Bonracino J . Protein sorting by tyrosine-based signals: adapting to the Ys and wherefores. Trends Cell Biol. 1997; 7(3):124-8. DOI: 10.1016/S0962-8924(96)10057-X. View

17.

Kawabata H, Tong X, Kawanami T, Wano Y, Hirose Y, Sugai S . Analyses for binding of the transferrin family of proteins to the transferrin receptor 2. Br J Haematol. 2004; 127(4):464-73. DOI: 10.1111/j.1365-2141.2004.05224.x. View

18.

Vogt T, Blackwell A, Giannetti A, Bjorkman P, Enns C . Heterotypic interactions between transferrin receptor and transferrin receptor 2. Blood. 2002; 101(5):2008-14. DOI: 10.1182/blood-2002-09-2742. View

19.

Richardson D, Ponka P . The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. Biochim Biophys Acta. 1997; 1331(1):1-40. DOI: 10.1016/s0304-4157(96)00014-7. View

20.

van Weert A, Dunn K, Geuze H, Maxfield F, Stoorvogel W . Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol. 1995; 130(4):821-34. PMC: 2199957. DOI: 10.1083/jcb.130.4.821. View